Skip to main content
Premium Trial:

Request an Annual Quote

That's Because Risk Is Small and Inertia Is Great

With personal genomics hitting the big time, Thomas Mailund wonders about the impact that risk assessments will have on consumer behavior -- and concludes that it will be nominal. Increases in risk of developing a disease such as cancer due to genetics is often small, from 0.1 percent to 0.15 percent, says Mailund. The risk associated with smoking and cancer is much larger, he adds, and that doesn't affect people's behavior, so why would genetics?

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.